Emergent Biosolutions Inc.
$702.71M- Market cap
- $318.41M
- Debt
- +$589.70M
- Cash
- −$205.40M
Capital structure 35% equity / 65% debt · EV / Revenue 0.95x · EV / EBITDA 2.95x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
EBS · current priceP/E 6.68x
$6.21Latest market snapshot
Implied fair value · at LUV's multiple
$46.64651.1% above market
0.93 EBS EPS (TTM)×50.15x LUV P/E=$46.64
Market $6.21Implied $46.64
LUV · current priceP/E 50.15x
$39.62Latest market snapshot
Implied fair value · at EBS's multiple
$5.2886.7% below market
0.79 LUV EPS (TTM)×6.68x EBS P/E=$5.28
Market $39.62Implied $5.28